Roche to sell flu pill for $50 to cash-paying US patients

Roche has announced that it will sell its flu pill for $50 to cash-paying patients in the U.S., making it more accessible for those without insurance. This move is significant as it addresses the rising demand for affordable healthcare solutions, especially during flu season when many seek effective treatments. By offering a lower price point, Roche aims to help more individuals manage their health without the burden of high costs.